Olaf Robert Heyden
CIK 1686746 · View on SEC EDGAR ↗
First SEC filing: March 10, 2023 · Latest: March 10, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 13, 2020 | DBD | P | 1,416 | $4.56 | $6,457 | 232,487 Direct | +0.61% | Acquired | 1396.5% (price as of 2026-08-19) |
| March 13, 2020 | DBD | P | 100 | $4.65 | $465 | 231,071 Direct | +0.04% | Acquired | 1367.5% (price as of 2026-08-19) |
| March 13, 2020 | DBD | P | 369 | $4.56 | $1,683 | 230,971 Direct | +0.16% | Acquired | 1396.5% (price as of 2026-08-19) |
| March 13, 2020 | DBD | P | 1,709 | $5.00 | $8,545 | 230,602 Direct | +0.75% | Acquired | 1264.8% (price as of 2026-08-19) |
| March 13, 2020 | DBD | P | 16,406 | $5.55 | $91,053 | 228,893 Direct | +7.72% | Acquired | 1129.5% (price as of 2026-08-19) |
| Feb. 28, 2020 | DBD | P | 1,000 | $6.95 | $6,950 | 212,487 Direct | +0.47% | Acquired | 881.9% (price as of 2026-08-19) |
| Feb. 28, 2020 | DBD | P | 12,000 | $7.06 | $84,720 | 211,487 Direct | +6.02% | Acquired | 866.6% (price as of 2026-08-19) |
| Oct. 31, 2019 | DBD | P | 1,000 | $6.98 | $6,980 | 160,202 Direct | +0.63% | Acquired | 877.7% (price as of 2026-08-19) |
| May 2, 2019 | DBD | P | 7,750 | $9.18 | $71,145 | 159,202 Direct | +5.12% | Acquired | 643.4% (price as of 2026-08-19) |
| May 2, 2019 | DBD | P | 4,900 | $9.15 | $44,835 | 151,452 Direct | +3.34% | Acquired | 645.8% (price as of 2026-08-19) |
| May 2, 2019 | DBD | P | 7,350 | $9.12 | $67,032 | 146,552 Direct | +5.28% | Acquired | 648.2% (price as of 2026-08-19) |
| March 4, 2019 | DBD | P | 9,870 | $9.07 | $89,521 | 139,202 Direct | +7.63% | Acquired | 652.4% (price as of 2026-08-19) |
| March 4, 2019 | DBD | P | 5,060 | $9.02 | $45,641 | 129,332 Direct | +4.07% | Acquired | 656.5% (price as of 2026-08-19) |
| March 4, 2019 | DBD | P | 5,070 | $8.98 | $45,529 | 124,272 Direct | +4.25% | Acquired | 659.9% (price as of 2026-08-19) |
| March 4, 2019 | DBD | P | 1,000 | $8.89 | $8,890 | 1,000 Indirect | — | Acquired | 667.6% (price as of 2026-08-19) |
| July 26, 2017 | DBD | P | 2,000 | $23.28 | $46,560 | 7,759 Direct | +34.73% | Acquired | 193.1% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (12,614) | $11.96 | Jan. 30, 2030 | 12,614 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (47,407) | $4.08 | Jan. 29, 2029 | 47,407 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (30,278) | $18.75 | Feb. 1, 2028 | 30,278 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F2] | Common Shares (49,650) | $26.60 | Feb. 8, 2027 | 49,650 | Disposed |
| Jan. 30, 2020 | DBD | Non-Qualified Stock Option [F5] | Common Shares (12,614) | $11.96 | Jan. 31, 2030 | 12,614 | Acquired |
| Jan. 29, 2019 | DBD | Non-Qualified Stock Option [F4] | Common Shares (47,407) | $4.08 | Jan. 29, 2029 | 47,407 | Acquired |
| Feb. 1, 2018 | DBD | Non-Qualified Stock Option [F1,F2] | Common Shares (30,278) | $18.75 | Feb. 1, 2028 | 30,278 | Acquired |
| Feb. 1, 2018 | DBD | Common Shares [F4] | Common Shares (44,427) | $18.75 | Feb. 1, 2028 | 44,427 | Acquired |
| Feb. 8, 2017 | DBD | Non-Qualified Stock Options [F3] | Common Shares (49,650) | $26.60 | Feb. 7, 2027 | 49,650 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | — | — | — | — | $397,427 | $81,180 | — | $1,823,105 |
| 2022 | — | — | — | — | — | $5,363 | — | $2,600,466 |
| 2021 | — | — | — | — | $692,925 | $54,610 | — | $2,788,652 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.